TRUFF OTC
Rhelion Life Sciences Corp.
1W: -17.3%
1M: -10.9%
3M: -9.4%
YTD: +18.4%
1Y: -18.0%
3Y: -62.7%
5Y: -89.1%
$0.02
-0.00 (-7.83%)
Weekly Expected Move ±19.7%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$2M
-63.3% ▼
Capital Expenditures
$140K
+73.6% ▲
5Y CAGR: -12.1%
Free Cash Flow
-$3M
-27.2% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$4M
-184.6% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$2M | -$6M | -$8M | -$4M | -$7M |
| Depreciation & Amort. | $36K | $630K | $931K | $777K | $358K |
| Stock-Based Comp. | $3M | $564K | $1M | $576K | $576K |
| Change in Working Capital | -$369K | -$676K | $125K | $1M | $488K |
| Other Non-Cash Items | $6K | $994K | $2M | $339K | $3M |
| Operating Cash Flow | -$3M | -$4M | -$3M | -$1M | -$2M |
| — Investing Activities — | |||||
| Capital Expenditures | -$268K | -$2M | -$694K | -$531K | -$140K |
| Acquisitions (Net) | -$1M | -$1M | $0 | $0 | $0 |
| Investment Purchases | -$350K | -$200K | $0 | $0 | $0 |
| Investment Sales | $2M | $148K | $11K | $0 | $0 |
| Other Investing | $162K | -$100K | $33K | $6K | -$1M |
| Investing Cash Flow | -$202K | -$3M | -$650K | -$525K | -$1M |
| — Financing Activities — | |||||
| Net Debt Issuance | $198K | -$164K | -$220K | $445K | -$766K |
| Stock Repurchased | $0 | $0 | -$89K | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $253K | $50K | $102K | $0 | $0 |
| Financing Cash Flow | $33M | -$114K | -$207K | $445K | -$766K |
| Net Change in Cash | $29M | -$8M | -$4M | -$2M | -$4M |
| Cash End of Period | $31M | $18M | $14M | $13M | $8M |
| Free Cash Flow | -$4M | -$6M | -$4M | -$2M | -$3M |